Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice
暂无分享,去创建一个
Keith C. Norris | A. Cheung | A. Nissenson | A. Kliger | W. Clark | C. Kjellstrand | J. Díaz-Buxó | J. Wish | R. Agarwal | M. Allon | T. Depner | R. Ward | K. Martin
[1] N. Powe,et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.
[2] Nina Vasavada,et al. Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. , 2003, Kidney international.
[3] C. Kjellstrand,et al. Blood Access and Daily Hemodialysis: Clinical Experience and Review of the Literature , 2003, ASAIO journal.
[4] S. Block,et al. The need for end-of-life care training in nephrology: national survey results of nephrology fellows. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] J. Holley,et al. Endocrinology and Dialysis: Issue and Therapies Series Editor: Jean L. Holley: Pregnancy in Dialysis Patients: A Review of Outcomes, Complications, and Management , 2003, Seminars in dialysis.
[6] C. Lenfant. Shattuck lecture--clinical research to clinical practice--lost in translation? , 2003, The New England journal of medicine.
[7] C. Saha,et al. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. , 2003, Kidney international.
[8] A. P. Heidenheim,et al. The London Daily/Nocturnal Hemodialysis Study--study design, morbidity, and mortality results. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] Francesco Locatelli,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.
[10] N. Levinsky. Controversies in nephrology: Con , 2003 .
[11] A. Moss. Too many patients who are too sick to benefit start chronic dialysis nephrologists need to learn to "just say no". , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] E. Friedman,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.
[13] M. Perazella. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension , 2003, Expert opinion on drug safety.
[14] K. Chow,et al. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. , 2003, Annals of internal medicine.
[15] Johanna T Dwyer,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.
[16] S. Efrati,et al. ACE inhibitors and survival of hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] R. Agarwal. Editorials: Assessment of Blood Pressure in Hemodialysis Patients , 2002, Seminars in dialysis.
[18] G. Johnson,et al. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] N. Berman,et al. An analysis of dialysis training in the United States and Canada. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] S. Linas. Dialysis training in the United States. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] Jackson T. Wright,et al. A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] F. Bruns,et al. Tidal Peritoneal Dialysis during Pregnancy Improves Clearance and Abdominal Symptoms , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[23] Anabela S Rodrigues,et al. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[24] R. Agarwal,et al. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] R. Agarwal,et al. Prediction of hypertension in chronic hemodialysis patients. , 2001, Kidney international.
[26] J. Díaz-Buxó,et al. Potential Hazards of Polyglucose , 2001, ASAIO journal.
[27] A. Collins,et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. , 2001, Journal of the American Society of Nephrology : JASN.
[28] G. Becker,et al. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. , 2001, The New England journal of medicine.
[29] D. Levine. Shared decision-making in dialysis:The new RPA/ASN guideline on appropriate initiation and withdrawal of treatment , 2001 .
[30] D. Levine. Exploring Ethical, Moral, and Legal Issues Related to Kidney Diseases , 2001 .
[31] W. Bennett. Divided loyalties: relationships between nephrologists and industry. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] A. Moss. Shared decision-making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] B. Kasiske,et al. Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.
[35] W. White,et al. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] John H. Galla,et al. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis , 2000 .
[37] Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort. , 2000, Clinical nephrology.
[38] C. L. Plante. 1971 Medicare amendment: reflections on the passage of the end-stage renal disease Medicare program. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] G. Bakris,et al. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.
[40] G. Schreiner,et al. How end-stage renal disease (ESRD)-medicare developed. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[42] W. van Biesen,et al. An evaluation of an integrative care approach for end-stage renal disease patients. , 2000, Journal of the American Society of Nephrology : JASN.
[43] G. Beck,et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. , 1999, Journal of the American Society of Nephrology : JASN.
[44] D. Tarng,et al. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. , 1999, Kidney international.
[45] I. Macdonald,et al. Occult hypoglycemia caused by hemodialysis. , 1999, Clinical nephrology.
[46] R. Agarwal. Supervised atenolol therapy in the management of hemodialysis hypertension. , 1999, Kidney international.
[47] R. Agarwal. Role of home blood pressure monitoring in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[49] M C Smith,et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[50] R. Mehta,et al. Assessment of dry weight in hemodialysis: an overview. , 1999, Journal of the American Society of Nephrology : JASN.
[51] A. Babrow,et al. Dialysis Patients' Preferences for Family-Based Advance Care Planning , 1999, Annals of Internal Medicine.
[52] G. Kaysen,et al. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[53] B. Scribner,et al. Blood pressure control in dialysis patients: importance of the lag phenomenon. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[54] Glassock Rj. Nephrology workforce and time allocation: important issues for the future. , 1998 .
[55] W. McClellan,et al. Patterns of patient care reported by nephrologists: implications for nephrology training. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[56] C. Kjellstrand,et al. Daily hemodialysis: dialysis for the next century. , 1998, Advances in renal replacement therapy.
[57] D. Sutherland,et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. , 1998, The New England journal of medicine.
[58] B. Charra. 'Dry weight' in dialysis: the history of a concept. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[59] D. Sheikh-Hamad,et al. Silent infection in clotted hemodialysis access grafts. , 1998, Journal of the American Society of Nephrology : JASN.
[60] D. Churchill,et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. , 1998, Journal of the American Society of Nephrology : JASN.
[61] T A Louis,et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[62] R. Glassock. Nephrology workforce and time allocation: important issues for the future. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[63] W. White,et al. Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[64] N. Madias,et al. Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. , 1997, Journal of the American Society of Nephrology : JASN.
[65] H. Ar. The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. , 1997 .
[66] Y. Kawaguchi,et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.
[67] A. Hull. The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. , 1997, Seminars in nephrology.
[68] C. Kjellstrand,et al. A prospective study of risk factors and decision making in discontinuation of dialysis. , 1996, Archives of internal medicine.
[69] R. Townsend,et al. Ambulatory blood pressure monitoring: coming of age in nephrology. , 1996, Journal of the American Society of Nephrology : JASN.
[70] S. Hou. Pregnancy in Women Treated with Peritoneal Dialysis: Viewpoint 1996 , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[71] J. Díaz-Buxó. Enhancement of peritoneal dialysis: the PD Plus concept. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[72] B. Charra,et al. Clinical assessment of dry weight. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[73] M. Rocco,et al. Changes in Peritoneal Transport during the First Month of Peritoneal Dialysis , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[74] D. Sica,et al. Hormonal, Blood Pressure, and Peritoneal Transport Response to Short -Term Ace Inhibition , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[75] B. Charra. Control of blood pressure in long slow hemodialysis. , 1994, Blood purification.
[76] P. Grayburn,et al. Effects of cooler temperature dialysate on hemodynamic stability in "problem" dialysis patients. , 1993, Kidney international.
[77] R. Converse,et al. Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.
[78] R. Converse,et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. , 1992, The Journal of clinical investigation.
[79] A. Nissenson. Morbidity and Mortality of United States Dialysis Patients—–The Legacy of Inadequate Nephrologist Training? , 1992 .
[80] B. Piraino,et al. Effectiveness of renal fellowship training for subsequent clinical practice. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[81] F. Portaluppi,et al. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. , 1991, American journal of hypertension.
[82] L. Fine. A proposal to improve the attractiveness of nephrology as a subspecialty choice for residents in internal medicine. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[83] F. Coronel,et al. Captopril, proteinuria and peritoneal protein leakage in diabetic patients. , 2008, Nephron.
[84] E. Pohanka,et al. PROGRESSION OF CHRONIC RENAL FAILURE , 1988, The Lancet.
[85] G. D'Amico,et al. Antihypertensive therapy in dialysed patients. , 1988, Contributions to nephrology.
[86] R. Ward,et al. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. , 1987, Kidney international.
[87] C. Kjellstrand,et al. Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. , 1986, The New England journal of medicine.
[88] W. Henrich,et al. The chronic efficacy and safety of high sodium dialysate: double-blind, crossover study. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[89] A. J. Man in 't Veld,et al. Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. , 1980, British medical journal.
[90] M. Grajower,et al. Hypoglycemia in chronic hemodialysis patients: association with propranolol use. , 1980, Nephron.
[91] B. Sprangers,et al. Core Curriculum in Nephrology , 2022 .